Literature DB >> 17362785

Stem cell transplantation: the lung barrier.

S Schrepfer1, T Deuse, H Reichenspurner, M P Fischbein, R C Robbins, M P Pelletier.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) show differentiation capacity along mesenchymal lineages and have the potential to aid tissue regeneration. MSC transplantation strategies are therefore currently being assessed following injury to various organs. However, potential MSC migration to these organs after intravenous (IV) MSC injection continues to be impeded by cell trapping within the lung.
METHODS: Mouse MSCs were isolated, purified, transfected with firefly luciferase, and labeled with CSFE. Their size was assessed in vitro. To estimate the diameter of mouse pulmonary capillaries, fluorescence-labeled microspheres of different sizes were injected with or without sodium nitroprusside (SN) pretreatment. The lungs were harvested after 30 seconds and mean numbers of trapped microspheres per high-power field (HPF) were calculated. After IV injection of MSC suspensions (with or without SN), their dynamic distribution was monitored by in vivo luciferine imaging as well as by histopathology.
RESULTS: The diameter of suspended MSCs in vitro was 15 to 19 microm. Whereas nearly no 4-microm microspheres could be detected in lung sections, the numbers of trapped 10- and 15-microm microspheres could be significantly decreased by prior SN injection from 19.3 +/- 11.1 to 6.0 +/- 1.6 cells/HPF (P = .004) and from 34.9 +/- 11.9 to 25.6 +/- 8.1 cells/HPF (P = .028), respectively. Within seconds after MSC IV injection, the vast majority of cells was found in the lungs. However, cell trapping in the pulmonary microvasculature was significantly reduced by pre-treatment with SN.
CONCLUSIONS: We demonstrate that cell trapping in lungs can be reduced with IV SN pretreatment, increasing MSC passage through the lung capillaries, and potentially facilitating cell access to injured organs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362785     DOI: 10.1016/j.transproceed.2006.12.019

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  240 in total

Review 1.  Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.

Authors:  Diptiman Chanda; Sanjay Kumar; Selvarangan Ponnazhagan
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

2.  Human Adipose-Derived Stem Cells Suppress Elastase-Induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion Through Paracrine Factors.

Authors:  Jie Xie; Thomas J Jones; Dongni Feng; Todd G Cook; Andrea A Jester; Ru Yi; Yameena T Jawed; Clifford Babbey; Keith L March; Michael P Murphy
Journal:  Cell Transplant       Date:  2016-07-18       Impact factor: 4.064

3.  Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound.

Authors:  Ali Ziadloo; Scott R Burks; Eric M Gold; Bobbi K Lewis; Aneeka Chaudhry; Maria J Merino; Victor Frenkel; Joseph A Frank
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

4.  Mesenchymal stem cell therapy: Two steps forward, one step back.

Authors:  James Ankrum; Jeffrey M Karp
Journal:  Trends Mol Med       Date:  2010-03-23       Impact factor: 11.951

5.  Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury.

Authors:  Hiroaki Haga; Irene K Yan; David A Borrelli; Akiko Matsuda; Mansi Parasramka; Neha Shukla; David D Lee; Tushar Patel
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

6.  No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.

Authors:  Mark van der Garde; Anneke Brand; Manon C Slot; Alice de Graaf-Dijkstra; Jaap Jan Zwaginga; Yvette van Hensbergen
Journal:  Stem Cells Dev       Date:  2015-03-13       Impact factor: 3.272

7.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect.

Authors:  Uwe M Fischer; Matthew T Harting; Fernando Jimenez; Werner O Monzon-Posadas; Hasen Xue; Sean I Savitz; Glen A Laine; Charles S Cox
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

8.  Up-regulation of CXCR4 in rat umbilical mesenchymal stem cells induced by serum from rat with acute liver failure promotes stem cells migration to injured liver tissue.

Authors:  Changqing Deng; Ailan Qin; Weifeng Zhao; Tingting Feng; Cuicui Shi; Tao Liu
Journal:  Mol Cell Biochem       Date:  2014-08-07       Impact factor: 3.396

9.  Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice.

Authors:  Atsushi Kuwabara; Jia Liu; Yoshinobu Kamio; Airan Liu; Michael T Lawton; Jae-Woo Lee; Tomoki Hashimoto
Journal:  Neurosurgery       Date:  2017-12-01       Impact factor: 4.654

10.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.